SMTL ID : 3lco.1

Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.40 Å

Oligo State

monomer

Ligands

1 x LC0: 3-({4-methoxy-5-[(4-methoxybenzyl)oxy]pyridin-2-yl}methoxy)-5-(1-methyl-1H-pyrazol-4-yl)pyrazin-2-amine(Non-covalent)

LC0.1: 17 residues within 4Å: Chain A: L.39, V.47, A.65, K.67, E.84, M.88, L.91, V.98, T.114, E.115, C.117, H.181, N.188, L.190, G.200, D.201, F.202 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.39, A:F.202 Hydrogen bonds: A:T.114, A:T.114, A:C.117, A:D.201

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Meyers, M.J. et al., Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-09-15

Peptides

Macrophage colony-stimulating factor 1 receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Macrophage colony-stimulating factor 1 receptor

Related Entries With Identical Sequence